Bharat Biotech Submits Phase-1 Trial Data of ‘Game Changer’ Intranasal Covid Vaccine

The company sought permission from the drug regulator for a change from nasal drop to spray; expert panel advised both drop and spray be used for clinical trials.

Similar Articles

Most Popular